Pre-market Hot Trades in US Stocks
Applied Optoelectronics pre-market down 5.14%. Based on recent key news:
<ol>
<li>
On May 14, Applied Optoelectronics announced a partnership with Mediacom to accelerate the upgrade and expansion of its fiber and hybrid fiber-coaxial network infrastructure. This move aims to avoid supply chain issues and enhance its value in the AI network market, leading to stock price fluctuations.
</li>
<li>
On May 14, Applied Optoelectronics entered into an equity distribution agreement, potentially issuing up to $600 million in common stock. This news raised market concerns about the stock price, resulting in a decline.
</li>
<li>
On May 12, analysts warned of a potential 25%-30% correction after recent strong growth, emphasizing the critical role of hyperscale spending and industry momentum in maintaining valuations. Demand in the optical communication industry remains strong, but risks persist.
</li>
</ol>
Astera Labs pre-market down 4.65%. Based on recent key news:
<ol>
<li>
On May 12, Astera Labs' CEO Jitendra Mohan sold 139,951 shares of common stock, raising concerns in the market about internal confidence in the company, putting pressure on the stock price. According to SEC filings, the transaction price ranged from $199.33 to $205.74.
</li>
<li>
On May 12, Astera Labs' President and COO Sanjay Gajendra sold 49,361 shares for a transaction amount of $9,833,295. This insider trading raised market doubts about the company's future performance, further impacting the stock price.
</li>
<li>
On May 12, global chip sales hit a quarterly record of $298.5 billion, with companies like Astera Labs expanding capacity to meet AI infrastructure demand. However, community opposition to large AI data centers may delay projects and disrupt supply chains, increasing market uncertainty. Demand in the semiconductor industry remains strong, driven by AI investments.
</li>
</ol>
Top Gainers in Pre-market US Stocks
HCW Biologics pre-market up 140.33%. Based on recent key news:
<ol>
<li>
On May 14, HCW Biologics announced that its candidate drug HCW11-040 showed effectiveness in preventing bronchopulmonary dysplasia in IND-enabled studies. This discovery boosted market confidence in the company's future development, driving a significant increase in stock price. Source: Reuters
</li>
<li>
On May 14, HCW Biologics released its Q1 2026 financial report, showcasing the company's progress and financial performance in the field of innovative combination immunotherapy. Positive data from the report further enhanced investor confidence. Source: Company announcement
</li>
<li>
On May 15, analysts rated HCW Biologics as &#34;Buy,&#34; predicting a target price of $2.00 for the next 12 months, which is 472.4% higher than the closing price on May 13
This optimistic analyst expectation has formed strong support for the stock price. Source: Reuters The biotechnology industry has recently shown active performance, with significant capital inflow.
</li>
</ol>
Dreamland pre-market rose 96.87%. Based on recent key news:
<ol>
<li>
On May 13, Dreamland's stock price surged 126.92%, with a transaction amount of approximately $219 million, indicating an extremely rare scale of capital inflow. Technical indicators show bullish signals, but considering the extreme single-day increase, it needs to be examined in conjunction with more dimensions. Source: Benzinga
</li>
<li>
On May 12, Dreamland signed a memorandum of understanding with LinkFung Innovation to explore the development and implementation of an AI technology platform. This move aims to enhance service capabilities through technology and expand market influence. Source: Benzinga
</li>
<li>
On May 14, technical indicators showed that Dreamland's stock price was severely overbought, with an RSI of 97.75, and the stock price far exceeded key moving averages, leading to heightened market optimism. Source: Benzinga The film and entertainment industry has not seen significant positive news recently.
</li>
</ol>
Murano Global BV pre-market rose 68.48%. Based on recent news,
<ol>
<li>
On May 11, Form 3 documents from Murano Global Investments showed that CEO Sacal Cababie Elias holds 69,152,609 shares of common stock. This news has strengthened market confidence in the company's management, driving the stock price significantly higher.
</li>
<li>
On May 11, Murano Global Investments appointed Oscar Jazmani Mendoza Escobar as Chief Financial Officer. The newly appointed executive is expected to bring a new strategic direction to the company, further boosting investor confidence.
</li>
<li>
On May 11, Murano Global Investments appointed Marcos Sacal Cohen as Chief Operating Officer and Director. The addition of the new executive is seen as a strengthening of the company's management, further driving up the stock price. The market reacted positively to the changes in the company's management
</li>
</ol>

AAOI

ALAB

Applied Optoelectronics pre-market down 5.14%; Astera Labs pre-market down 4.65%; HCW Biologics pre-market up 140.33%; Dreamland pre-market up 96.87%; Murano Global BV pre-market up 68.48%

Price Alert

Applied Optoelectronics

Pre-market hot trades in US stocks: Applied Optoelectronics fell 5.14% in pre-market; Astera Labs fell 4.65% in pre-market